Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan

Neurology

Volumn 82, Issue 8, 2014, Pages 705-712

  Yamada, Megumi ^a,g   Tanaka, Masaki ^b   Takagi, Mari ^a   Kobayashi, Seiju ^c   Taguchi, Yoshiharu ^d   Takashima, Shutaro ^d   Tanaka, Kortaro ^d   Touge, Tetsuo ^e   Hatsuta, Hiroyuki ^f   Murayama, Shigeo ^f   Hayashi, Yuichi ^a,g   Kaneko, Masayuki ^a   Ishiura, Hiroyuki ^b   Mitsui, Jun ^b   Atsuta, Naoki ^b   Sobue, Gen ^b   Shimozawa, Nobuyuki ^h   Inuzuka, Takashi ^g   Tsuji, Shoji ^b   Hozumi, Isao ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

^d TOYAMA UNIVERSITY HOSPITAL   (Japan)

^e KAGAWA UNIVERSITY HOSPITAL   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^g Department of Neurology and Geriatrics ^*  (Japan)

^h GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FAHR DISEASE; FAMILY; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; IDIOPATHIC BASAL GANGLIA CALCIFICATION; JAPAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MISSENSE MUTATION; MOLECULAR EPIDEMIOLOGY; MUTATIONAL ANALYSIS; NEUROIMAGING; NONSENSE MUTATION; PRIORITY JOURNAL;

ADULT; AGED; BASAL GANGLIA DISEASES; BRAIN; CALCINOSIS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTATION; NEURODEGENERATIVE DISEASES; PEDIGREE; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III; YOUNG ADULT;

EID: 84895793619     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000143     Document Type: Article

References (31)

1. Manyam BV. What is and what is not "Fahr's disease." Parkinsonism Relat Disord 2005;11:73-80.
2. Bonazza S, La Morgia C, Martinelli P, Capellari S. Striopallido-dentate calcinosis: a diagnostic approach in adult patients. Neurol Sci 2011;32:537-545.
3. Sobrido MJ, Hopfer S, Geschwind DH. Familial idiopathic basal ganglia calcification. In: GeneReviews NCBI Bookshelf [online]. Available at: http://www.ncbi.nlm.nih. gov/books/NBK1421/. Accessed March 1, 2013.
4. Geschwind DH, Loginov M, Stern JM. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet 1999;65:764-772.
5. Lemos RR, Oliveira DF, Zatz M, Oliveira JR. Population and computational analysis of the MGEA6 P521A variation as a risk factor for familial idiopathic basal ganglia calcification (Fahr's disease). J Mol Neurosci 2011;43:333-336.
6. Oliveira JR, Spiteri E, Sobrido MJ, et al. Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology 2004;63:2165-2167.
7. Volpato CB, De Grandi A, Buffone E, et al. 2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family. J Mol Neurosci 2009;39:346-353.
8. Dai X, Gao Y, Xu Z, et al. Identification of a novel genetic locus on chromosome 8p21.1-q11.23 for idiopathic basal ganglia calcification. Am J Med Genet B Neuropsychiatr Genet 2010;7:1305-1310.
9. Wang C, Li Y, Shi L, et al. Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet 2012;44:254-256.
10. Hsu SC, Sears RL, Lemos RR, et al. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics 2013;14:11-22.
11. Zhang Y, Guo X, Wu A, et al. Association between a novel mutation in SLC20A2 and familial idiopathic basal ganglia calcification. PLoS One 2013;8:e57060.
12. Lemos RR, Oliveira MF, Oliveira JR. Reporting a new mutation at the SLC20A2 gene in familial idiopathic basal ganglia calcification. Eur J Neurol 2013;20:e43-e44.
13. Nicolas G, Pottier C, Maltête D, et al. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology 2013;80:181-187.
14. Chen WJ, Yao XP, Zhang QJ, et al. Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification. Gene 2013;529:159-162.
15. Keller A, Westenberger A, Sobrido MJ, et al. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet 2013;45:1077-1082.
16. Adzhubei IA, Schmidt S, Peshkin L. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-249.
17. Kosaka K. Diffuse neurofibrillary tangles with calcification: a new presenile dementia. J Neurol Neurosurg Psychiatry 1994;57:594-596.
18. Yamada M, Asano T, Okamoto K, et al. High frequency of calcification in basal ganglia on brain computed tomography images in Japanese older adults. Geriatr Gerontol Int 2013;13:706-710.
19. Chung AJ, Cho G, Kim SJ. A case of paroxysmal kinesigenic dyskinesia in idiopathic bilateral striopallidodentate calcinosis. Seizure 2012;21:802-804.
20. Alemdar M, Selek A, Iseri P, Efendi H, Komsuoglu SS. Fahr's disease presenting with paroxysmal non-kinesigenic dyskinesia: a case report. Parkinsonism Relat Disord 2008; 14:69-71.
21. Chen WJ, Lin Y, Xiong ZQ, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011;43; 1252-1255.
22. Fabbri M, Marini C, Bisulli F, et al. Clinical and polygraphic study of familial paroxysmal kinesigenic dyskinesia with PRRT2 mutation. Epileptic Disord 2013;15: 123-127.
23. Lederer E, Miyamoto K. Clinical consequences of mutations in sodium phosphate cotransporters. Clin J Am Soc Nephrol 2012;7:1179-1187.
24. Feild JA, Zhang L, Brun KA, Brooks DP, Edwards RM. Cloning and functional characterization of a sodiumdependent prostate transporter expressed in human lung and small intestine. Biochem Biophys Res Commun 1999; 258:578-582.
25. Huqun, Izumi S, Miyazawa H, et al. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med 2007;175: 263-268.
26. Hozumi I, Kohmura A, Kimura A, et al. High levels of copper, zinc, iron and magnesium, but not calcium, in the cerebrospinal fluid of patients with Fahr's disease. Case Rep Neurol 2010;2:46-51.
27. Takagi M, Ozawa K, Yasuda H, et al. Decreased bioelements content in the hair of patients with Fahr's disease (idiopathic bilateral calcification in the brain). Biol Trace Elem Res 2013;159:9-13.
28. Inden M, Iriyama M, Takagi M, et al. Localization of type-III sodium-dependent phosphate transporter 2 in the mouse brain. Brain Res 2013;1531:75-83.
29. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008;22:1276-1312.
30. Giachelli CM, Jono S, Shioi A, et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis 2001;38(4 suppl 1):S34-S37.
31. Jensen N, Schrøder HD, Hejbøl EK, et al. Loss of function of Slc20a2 associated with familial idiopathic basal ganglia calcification in humans causes brain calcifications in mice. J Mol Neurosci 2013;51:994-999.